and netherlands remains at 200.000 vaccinations


no one vaccinated today (out of protest that we can't get astrazeneca)

From today's Sunday Times.
(from BBC1HD Marr paper review)



The OxfordAstraZeneca Vaccine is brewed in Oxford & Keele
put into the small glass Vials
in Wrexham in Wales, but alot is sent to Germany
to be put into the Vials
then sent back to Oxford.

https://i2-prod.walesonline.co.uk/in...ov-30-2020.jpg


All the way to Germany
and back.

Lucky 7.


https://i.dailymail.co.uk/1s/2021/01...2043347816.jpg

9 million, that is amazing. We can do this!

The Wisconsin pharmacist who intentionally sabotaged hundreds of doses of the Moderna coronavirus vaccine because he thought COVID-19 was a hoax, also believes the earth is flat and the sky is actually a “shield put up by the Government to prevent individuals from seeing God.”


https://uk.yahoo.com/news/wisconsin-...193736813.html

This type of crap is spreading to the UK fast, something has to be done

Sounds like he’s been taking something that’s damaged him..


Sent from my iPhone using Tapatalk Pro

close down FB for starters :laugh:

Yesterdays.


https://pbs.twimg.com/media/EtKbl8rX...pg&name=medium

More than 100 million Covid-19 vaccines have been given around the world, an AFP tally from official sources found today.

But none of the world's 29 poorest countries has formally started mass vaccination drives, while the richest nations have given more than two-thirds of jabs administered.

Israel leads the race by far, with 37% of its population having received at least one dose, while more than a fifth have already got their second.

Yet more than a third of humanity (35%) live in countries where vaccination has yet to begin.

After Israel, the countries that have given the most doses are in North America, Europe and the Persian Gulf.

The UK heads this group in per capita terms with shots given to 13.7% of its people, ahead of the US (32.2 million shots to 7.9%).

The European Union has been clashing bitterly with AstraZeneca over access to supplies of its vaccine, with only 12.7 million shots given to 2.3% of its people.

China by contrast has given 24 million shots, while India - where many of the vaccines are made - has given only four million to a tiny percentage of its vast population.

The EU's best performing countries are tiny Malta (5.4%), Denmark (3.2%) and Poland (3.1%).

Latest coronavirus stories

The UK's nearest competitor in Europe is Serbia, which is also outside the bloc.

It has given the Chinese Sinopharm and Russia's Sputnik V jabs to 6.2% of its population.

The EU has vowed to continue discussion with pharmaceutical company AstraZeneca for increasing vaccine supply following the company's promise to deliver nine million additional doses in the first quarter of this year to the EU nations, said a spokesperson for the European Commission said yesterday.

The spokesperson said AstraZeneca's promise to increase its vaccine supply to the EU is constructive, but the amount is not what they expected to deliver at the end of the first quarter of this year, so the discussion will keep on.

On Sunday, the European Commission held a video conference with representatives of a number of pharmaceutical companies to discuss the rapid development and production of vaccines against the mutated new coronavirus.

European Commission President Ursula von der Leyen announced the same day that "AstraZeneca will deliver 9 million additional doses in the first quarter (40 million in total) ".

AstraZeneca announced in January that due to production restrictions and other issues, only 31 million doses of vaccines could be delivered to the EU in the first quarter of this year, which is much less than the promised quota of 80 million doses.

The AstraZeneca was the first vaccine producer that the EU has signed an early purchase agreement with in the effort to prevent the Covid-19 from further spread.

According to the agreement signed last August, the European Commission, on behalf of the EU states, purchased 300 million doses, with an option to buy 100 million more.

The AstraZeneca vaccine was approved for conditional marketing in the EU on Friday, after the European Medicines Agency gave a positive assessment for its safety and effectiveness. It was the the third Covid-19 vaccine greenlighted by the EU.

As the world is struggling to contain the pandemic, vaccination is being rolled out across the whole EU with the already-authorized coronavirus vaccines.

Meanwhile, 236 candidate vaccines are still being developed worldwide - 63 of them in clinical trials - in countries including Germany, China, Russia, Britain and the United States, according to information released by the WHO on 26 January.

With the World Health Organization lamenting that "rich countries are rolling out vaccines while least-developed countries watch and wait," 101,317,005 jabs had been given in 77 mostly wealthy countries and territories, AFP's count found.

Some rich countries, however, have yet to start vaccinating, including Japan, South Korea and Australia, which have managed to contain the pandemic with strict border controls and quarantines.

The first deliveries of the WHO's Covax scheme to share shots more fairly are due begin this month. So far only Guinea has benefited, with only a few dozen given in a pilot trial.

There are currently seven vaccines circulating around the world, all designed to be given in two doses.
The vaccines developed by Pfizer-BioNTech (US-German) and Moderna (US) are dominant in North America, Europe, Israel and the Gulf.

Britain's AstraZeneca-Oxford is used in much of the UK and India, Myanmar, Sri Lanka and Morocco, and is soon to be rolled out in Europe.

India also uses a homegrown vaccine produced by Bharat Biotech.

Russia's Sputnik V vaccine has been rolled out in Russia, Argentina, Algeria, Belarus and Serbia.

China's Sinopharm jabs are being administered in China, the United Arab Emirates, Bahrain, Serbia the Seychelles and Jordan, while Indonesia and Turkey are using China's Sinovac vaccine.

China's Sinovac and Sinopharm vaccines and Russia's Sputnik V jab have yet to be fully approved by either Beijing or Moscow's health authorities.

https://www.rte.ie/news/2021/0202/11...covid19-world/

Here's a big part of the issue;

Covid mainly presents as severe in people over the age of 65, and the vast, VAST majority of Covid deaths are in that age category as well. Thus, covid will "appear" by the numbers to be "more widespread" in affluent countries where

A) There is an older population to present severe symptoms,

B) There will be a much higher number of deaths because of age profile (to be blunt, 80 year olds aren't really a thing in the first place in the poorest countries)

C) There is unlikely to be widescale testing for people with milder symptoms not requiring treatment in poor countries, those people will just go about their day and recover in 1 - 2 weeks.

In short, these countries will likely NEVER be flagged as huge hot spots, because they simply DO NOT HAVE an elderly population to be severely affected and thus their death rates will never shoot upwards.


Why this is a problem -

The West will have full-coverage vaccination programmes that are likely to be effective in stamping out current strains and numbers will go way down. However in the meantime, the virus is still circulating "quietly" (mild symptoms/asymptomatic) in other parts of the world... which means potential for mutations... which then enter vaccinated countries and (potentially) cause more infections. The vaccines now that they exist can be fairly rapidly altered for a new strain and rolled out again - however it is a bit of a "repeating forever" situation... wide vaccine coverage in poorer countries is simply NOT going to happen. Funds and logistics aside, they simply don't have the infrastructure... it's a practical impossibility.

Essentially I think we're looking at monitoring new strains and seasonal vaccination of the elderly and vulnerable for the foreseeable future until natural immunity builds in the 2/3 of the global population that probably isn't going to get within sniffing distance of a vaccine.

TS

[A mutation of the Kent variant detected in some
samples could help the virus evade the immune
system, scientists have found.

The mutation, which has been labelled E484K,
has also been found in the South Africa variant
of the coronavirus.
It was found in 11 samples of some
200,000 that have been sequenced.

SkyNews science correspondent Thomas Moore said it
was a "worrying development" as it could mean
those previously infected could be re-infected
and could reduce the effectiveness of COVID vaccines.]

https://news.sky.com/story/covid-19-...ystem-12206375

...this has always been the worry with the variants...it’s been impossible to say for sure that the vaccines will still be effective because so much is still unknown as to how the virus will mutate and how quickly...